연구 및 보고서
2026년 9월 14일•1분 읽기
Global Type 1 Diabetes Cases Projected to Rise 30% by 2049, Study Finds
A Danish research team projects worldwide type 1 diabetes patients will increase from 9.4 million to about 12.1 million by 2049, a 30% rise, with new cases up 14%.
연구 및 보고서
2026년 9월 6일•1분 읽기
BioSolution and Merck Life Science Unveil Animal‑Free Testing Solution at CPHI Korea 2026
BioSolution partnered with Merck Life Science to showcase a combined 3D human tissue model and precision analysis workflow for animal‑alternative testing at CPHI Korea 2026.
연구 및 보고서
2026년 8월 30일•1분 읽기
Acelra Presents Phase 1 Results of ACL-508 at NLA Conference
Acelra, the new‑drug subsidiary of Jonggeundang, reported Phase 1 data for its CETP inhibitor ACL‑508, aimed at lowering LDL‑C and raising HDL‑C, at the NLA annual meeting in Chicago.
연구 및 보고서
2026년 8월 24일•1분 읽기
PMDA Workshop on New Approach Methodologies (NAMs) Held after ICCR‑20
The Pharmaceuticals and Medical Devices Agency (PMDA) held a workshop on New Approach Methodologies (NAMs) following the ICCR‑20 symposium.
1